Arthneeti
Sale is live|00:00:00
Ion Exchange (India) LtdQ2 FY23

Ion Exchange (India) Ltd Q2 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 399P/E: 29.5Market Cap: ₹5.7K CrSector: Other Utilities

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

Yes

Order

Yes

Capex

Yes

4 of 5 growth signals are positive — a strong management growth story.

Full analysis

Revenue guidance

Category 2
  • Engineering segment expected to grow around 30%-35% in the current year with sustained momentum over the next 10-15 years due to increased domestic manufacturing and expanding industrial capacities.
  • Chemical segment anticipated growth of approximately 10%-15% for the current year, with 50% additional capacity utilization possible from existing plants; new resin facility expected to provide a step-up in growth.
  • Consumer business projected to grow multiples in the next 2-3 years, showing strong recent quarterly growth and scaling efforts underway.
  • Order book expected to end the year higher than before, with sizable and some large orders anticipated, supporting revenue growth.
  • New projects like Roha plant to start operations by FY25-26, contributing to future volume and revenue growth.
  • Innovation and improved product mix across segments aimed at enhancing value addition and margins, supporting sustainable growth.

Margin guidance

Category 1
  • Engineering segment expected to grow at 30%-35% in the current year and maintain momentum over the next 10-15 years due to sustained capital addition and industrial growth in India and other developing markets.
  • Chemical segment anticipates 10%-15% revenue growth this year, aided by capacity utilization improvements and a new resin facility expected to provide substantial step-up in growth and margins.
  • Margins in the chemical segment are improving, with expectations to reach breakeven soon, followed by a good pace of margin expansion due to favorable product gross margins.
  • Engineering segment margins are expected to improve as execution picks up; higher employee expenses now are investments for future growth.
  • Consumer business aims to grow multiples in two to three years and reach EBIT positive by the end of the current year.
  • Overall EBITDA and PAT for the current year are guided to improve with the ongoing order book execution and operational leverage.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes
  • The company is funding its Greenfield expansion project at Roha partly through internal accruals and partly via external financing.
  • The total CAPEX for the Roha project is around Rs. 400 crores.
  • The external funding portion is roughly 80% of the project cost, implying about Rs. 300-320 crores of debt over two years of project execution.
  • No explicit mention of future equity fundraising was made in the provided pages.
  • The company appears to be relying primarily on a mix of internal accruals and debt financing for upcoming expansion projects.

Order book

Yes
  • The company expects to end the year with an order book higher than previously seen.
  • Hit/conversion ratio is anticipated around 15%-20%, an improvement from earlier 10%-15%.
  • Sizable and some very large orders are expected, though the numbers of very large orders will be limited.
  • Bid pipeline is close to Rs. 8,600 crores, with a typical conversion rate around 20%.
  • Outstanding order book related to UP and Delhi projects is Rs. 925 crore.
  • Execution for some projects (e.g., UP) has been slower but expected to pick up in coming quarters.
  • International orders comprise just under 20% of the order book.
  • The order inflow for the recent quarter was about Rs. 187 crores.
  • Overall, the company is hopeful of scaling up the order book with improved product profile and geographic expansion.

Capex plans

Yes
  • The company has started executing a Greenfield expansion project at Roha with a total CAPEX of around Rs. 400 crores, expected to be operational by FY25-26.
  • Roha project funding is partly through internal accruals and partly through external financing (around Rs. 300-320 crores debt over two years).
  • Continuous investments are being made to scale operations, improve capabilities, and reposition for future growth, including adding manpower at senior levels.
  • Investment in innovative chemical technology and backward integration aims to improve cost efficiency and competitiveness.
  • Expansion in the consumer products segment to scale growth multiples in the next 2-3 years.
  • Ongoing investment in capabilities to capitalize on growth in engineering and chemicals sectors, supporting a target of 30-35% growth in engineering and 10-15% in chemicals.

How does Ion Exchange (India) Ltd rank vs peers in Other Utilities?

Pro feature
1Ion Exchange (India) Ltd
Rev 2Mar 1

See full Other Utilities sector rankings

Want more stocks like Ion Exchange (India) Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio